APO RESEARCH · REPORT
Famciclovir API
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
Product & engineering
Understand the product.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
Selected research
Market Structure
Global Famciclovir API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Read the full market overview
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report provides an overview of the global Famciclovir API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Famciclovir API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Famciclovir API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Famciclovir API market size, projected growth trends, production technologies, key applications, and end-use industries.
Famciclovir API Segment by Company
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Famciclovir API Segment by Type
Insourced
Outsourced
Others
Famciclovir API Segment by Application
Tablet Product
Capsule Product
Others
Famciclovir API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Famciclovir API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Famciclovir API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Famciclovir API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Famciclovir API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Insourced
- Outsourced
- Others
Applications
- Tablet Product
- Capsule Product
- Others
Companies covered
- Chongqing Shenghuaxi Pharma
- Aurobindo Pharma Limited
- Apotex Pharmachem
- Changzhou Kony Pharma Co
- Teva Pharmaceutical Industries
- Olon
- Fuan Pharmaceutical
- Zhejiang Charioteer Pharmaceutical
- Jialin Pharmaceutical
- Zhejiang Hisun
- Hetero
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Famciclovir API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Famciclovir API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Famciclovir API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Famciclovir API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Famciclovir API Market Dynamics
- 2.1 Famciclovir API Industry Trends
- 2.2 Famciclovir API Industry Drivers
- 2.3 Famciclovir API Industry Opportunities and Challenges
- 2.4 Famciclovir API Industry Restraints
3 Famciclovir API Market by Manufacturers
- 3.1 Global Famciclovir API Revenue by Manufacturers (2021-2026)
- 3.2 Global Famciclovir API Sales by Manufacturers (2021-2026)
- 3.3 Global Famciclovir API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Famciclovir API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Famciclovir API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Famciclovir API Manufacturers, Product Type & Application
- 3.7 Global Famciclovir API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Famciclovir API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Famciclovir API Players Market Share by Revenue in 2025
- 3.8.3 2025 Famciclovir API Tier 1, Tier 2, and Tier 3
4 Famciclovir API Market by Type
- 4.1 Famciclovir API Type Introduction
- 4.1.1 Insourced
- 4.1.2 Outsourced
- 4.1.3 Others
- 4.2 Global Famciclovir API Sales by Type
- 4.2.1 Global Famciclovir API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Famciclovir API Sales by Type (2021-2032)
- 4.2.3 Global Famciclovir API Sales Market Share by Type (2021-2032)
- 4.3 Global Famciclovir API Revenue by Type
- 4.3.1 Global Famciclovir API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Famciclovir API Revenue by Type (2021-2032)
- 4.3.3 Global Famciclovir API Revenue Market Share by Type (2021-2032)
5 Famciclovir API Market by Application
- 5.1 Famciclovir API Application Introduction
- 5.1.1 Tablet Product
- 5.1.2 Capsule Product
- 5.1.3 Others
- 5.2 Global Famciclovir API Sales by Application
- 5.2.1 Global Famciclovir API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Famciclovir API Sales by Application (2021-2032)
- 5.2.3 Global Famciclovir API Sales Market Share by Application (2021-2032)
- 5.3 Global Famciclovir API Revenue by Application
- 5.3.1 Global Famciclovir API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Famciclovir API Revenue by Application (2021-2032)
- 5.3.3 Global Famciclovir API Revenue Market Share by Application (2021-2032)
6 Global Famciclovir API Sales by Region
- 6.1 Global Famciclovir API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Famciclovir API Sales by Region (2021-2032)
- 6.2.1 Global Famciclovir API Sales by Region (2021-2026)
- 6.2.2 Global Famciclovir API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Famciclovir API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Famciclovir API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Famciclovir API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Famciclovir API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Famciclovir API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Famciclovir API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Famciclovir API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Famciclovir API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Famciclovir API Revenue by Region
- 7.1 Global Famciclovir API Revenue by Region
- 7.1.1 Global Famciclovir API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Famciclovir API Revenue by Region (2021-2026)
- 7.1.3 Global Famciclovir API Revenue by Region (2027-2032)
- 7.1.4 Global Famciclovir API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Famciclovir API Revenue (2021-2032)
- 7.2.2 North America Famciclovir API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Famciclovir API Revenue (2021-2032)
- 7.3.2 Europe Famciclovir API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Famciclovir API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Famciclovir API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Famciclovir API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Famciclovir API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Chongqing Shenghuaxi Pharma
- 8.1.1 Chongqing Shenghuaxi Pharma Company Information
- 8.1.2 Chongqing Shenghuaxi Pharma Business Overview
- 8.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolio
- 8.1.5 Chongqing Shenghuaxi Pharma Recent Developments
- 8.2 Aurobindo Pharma Limited
- 8.2.1 Aurobindo Pharma Limited Company Information
- 8.2.2 Aurobindo Pharma Limited Business Overview
- 8.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Aurobindo Pharma Limited Famciclovir API Product Portfolio
- 8.2.5 Aurobindo Pharma Limited Recent Developments
- 8.3 Apotex Pharmachem
- 8.3.1 Apotex Pharmachem Company Information
- 8.3.2 Apotex Pharmachem Business Overview
- 8.3.3 Apotex Pharmachem Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Apotex Pharmachem Famciclovir API Product Portfolio
- 8.3.5 Apotex Pharmachem Recent Developments
- 8.4 Changzhou Kony Pharma Co
- 8.4.1 Changzhou Kony Pharma Co Company Information
- 8.4.2 Changzhou Kony Pharma Co Business Overview
- 8.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Changzhou Kony Pharma Co Famciclovir API Product Portfolio
- 8.4.5 Changzhou Kony Pharma Co Recent Developments
- 8.5 Teva Pharmaceutical Industries
- 8.5.1 Teva Pharmaceutical Industries Company Information
- 8.5.2 Teva Pharmaceutical Industries Business Overview
- 8.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Pharmaceutical Industries Famciclovir API Product Portfolio
- 8.5.5 Teva Pharmaceutical Industries Recent Developments
- 8.6 Olon
- 8.6.1 Olon Company Information
- 8.6.2 Olon Business Overview
- 8.6.3 Olon Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Olon Famciclovir API Product Portfolio
- 8.6.5 Olon Recent Developments
- 8.7 Fuan Pharmaceutical
- 8.7.1 Fuan Pharmaceutical Company Information
- 8.7.2 Fuan Pharmaceutical Business Overview
- 8.7.3 Fuan Pharmaceutical Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Fuan Pharmaceutical Famciclovir API Product Portfolio
- 8.7.5 Fuan Pharmaceutical Recent Developments
- 8.8 Zhejiang Charioteer Pharmaceutical
- 8.8.1 Zhejiang Charioteer Pharmaceutical Company Information
- 8.8.2 Zhejiang Charioteer Pharmaceutical Business Overview
- 8.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolio
- 8.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments
- 8.9 Jialin Pharmaceutical
- 8.9.1 Jialin Pharmaceutical Company Information
- 8.9.2 Jialin Pharmaceutical Business Overview
- 8.9.3 Jialin Pharmaceutical Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jialin Pharmaceutical Famciclovir API Product Portfolio
- 8.9.5 Jialin Pharmaceutical Recent Developments
- 8.10 Zhejiang Hisun
- 8.10.1 Zhejiang Hisun Company Information
- 8.10.2 Zhejiang Hisun Business Overview
- 8.10.3 Zhejiang Hisun Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zhejiang Hisun Famciclovir API Product Portfolio
- 8.10.5 Zhejiang Hisun Recent Developments
- 8.11 Hetero
- 8.11.1 Hetero Company Information
- 8.11.2 Hetero Business Overview
- 8.11.3 Hetero Famciclovir API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hetero Famciclovir API Product Portfolio
- 8.11.5 Hetero Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Famciclovir API Value Chain Analysis
- 9.1.1 Famciclovir API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Famciclovir API Production Mode & Process
- 9.2 Famciclovir API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Famciclovir API Distributors
- 9.2.3 Famciclovir API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst